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D istal arteries are muscular arteries of small diameter and high resistance. Their wall is composed of one or few layers of smooth muscle cells (SMC) that confer the myogenic response, which refers to the property of these arteries in modulating their diameter in response to changes in intravascular pressure. Myogenic response involves a graded SMC depolarization that activates L-type voltage-dependent calcium (Ca 2+ ) channels, leading to elevation of the cytosolic Ca 2+ concentration, SMC contraction, and vasoconstriction. Myogenic reactivity is key in the setting of vascular resistance and local control of microvascular blood flow. 1 It is particularly well developed in brain arteries, where it is a major contributor to the maintenance of cerebral blood flow during variations in systemic blood pressure. 2 In humans, small artery disease of the brain accounts for >25% of strokes and is a leading cause of cognitive decline and disability. 3 The Notch signaling pathway is an evolutionarily conserved, intercellular signaling mechanism that plays a critical role in the development and homeostasis of blood vessels. 4 Endothelial Notch signaling is required for several critical steps in angiogenesis, including arterial-venous specification, tip cell differentiation, as well as growth and stability of the blood vessel network. 5 Also, Notch signaling positively regulates multiple aspects of vascular SMC (vSMC) specification, differentiation, and maturation. There are 4 Notch receptors (Notch1 to Notch4) in mammals, but several lines of evidence indicate that Notch3, which is predominantly expressed in vSMC, is the key Notch receptor in distal arteries and particularly in the brain arteries. 6 Targeted mutagenesis that disrupts Notch3 in the mouse results in a failure of arterial differentiation and maturation of vSMC in distal arteries, including the cerebral arteries. 7 Mice deficient for Notch signaling in vSMC or lacking Notch3 exhibit profound defects in cerebrovascular patterning. 8, 9 Notch3 deficiency strongly impacts myogenic tone of distal arteries and particularly of brain arteries. 10 This results in strongly compromised autoregulation of cerebral blood flow and increased susceptibility to ischemic stroke upon challenge. 7, 11 Importantly, dominant mutations of NOTCH3 cause CADASIL, an adult-onset small vessel disease of the brain in humans. 12 In response to ligand activation, Notch receptors undergo a series of proteolytic cleavages, resulting in the release of the Notch intracellular domain from the plasma membrane. After translocation to the nucleus, Notch intracellular domain binds to the transcription factor RBP-Jκ and coactivator Mastermind to activate transcription of genes by turning RBP-Jκ from a repressor to an activator. 13 Alternatively, in some forms of noncanonical signaling, Notch activation can trigger cellular responses without the involvement of RBP-Jκ. 14, 15 Importantly, there is a major diversity in the immediate downstream Notch response, as revealed by the analysis of Notch-induced transcriptomes in different cellular types and contexts. 16, 17 The downstream mechanisms of Notch3 signaling in the context of distal arteries and particularly of brain arteries remain poorly known. The Hes and Hey genes, the most wellcharacterized immediate Notch target genes, are unchanged in distal arteries of Notch3-null mice. 18 So far, only a few Notch downstream effectors, including platelet-derived growth factor receptor-β and integrin-β3, have been shown to be involved in maturing small arteries. 19, 20 To explore the molecular mechanisms acting downstream of Notch3, we used a combination of mouse models with constitutive deletion of Notch3, inducible deletion of RBP-Jκ in SMC, or transient pharmacological blockade of the Notch pathway to carry out transcriptome analysis and quantitative reverse transcription polymerase chain reaction (QRT-PCR) on isolated distal arteries. Herein, we report the identification of a core set of novel Notch3-RBP-Jκ regulated genes, including immediate and persistent responders of importance for brain artery function. For example, we uncover, for the first time to our knowledge, the glutamate receptor-interacting protein 2 (Grip2 protein) as a regulator of myogenic activity in the cerebrovasculature.
Materials and Methods
An expanded version is provided in the online-only Data Supplement.
Animal Studies
The Notch3 -/-(C57BL/6J), 7 RBP-Jκ flox/flox (C57BL/6J), 21 SMMHC-CreER T2 (C57BL/6J), 22 notch activity sensor (C57BL/6J), 18, 23 and Grip2 mutant 24 lines (C57BL/6J) have been described previously. SM-RBP-J-KO mice were generated by cross-breeding RBP-Jk flox/flox with SMMHC-Cre ERT2 mice; deletion was induced at postnatal day 1 by intragastric injection of tamoxifen. SMMHC-Cre ERT2 mice crossed with Rosa26-Stopfl-LacZ reporter mice 25 were used to monitor tamoxifen-induced Cre/Lox recombination ( Figure I in the online-only Data Supplement). Transient Notch pathway blockade was achieved by intraperitoneal injection of the γ-secretase inhibitor (GSI) LY-411575 (kind gift from Dr Todd Golde) to sort out, within the list of genes regulated by Notch3/RBP-Jκ, those that quickly respond to Notch inhibition. The experimental procedures conformed to the national guidelines for the use of animals in research and were approved by the Ethics committees on animal experiment (regional committee of Paris, Ile de France n°4, and local committee of University Paris Diderot, Lariboisière-Villemin).
Gene Expression Analysis
Caudal artery cRNAs were hybridized to Mouse Genome 430 2.0 oligonucleotide arrays at the IGBMC microarray Core Facility. Array data were processed using Gene Chip operating Software (GCOS v1, Affymetrix, Santa Clara, CA), and analysis of gene expression profiles was done using Robust Multichip Average. 26 The Student t test was used to evaluate differential expression, and the Westfall-Young permutation method was used to perform multiple test correction (resampling P value). The array data are available at Gene Expression Omnibus at the National Center for Biotechnology Information (accession no. GSE36437).
QRT-PCR analysis was performed on a MyiQ Single-Color Real-Time PCR detection system (Biorad), as previously described. 18 In situ hybridization was performed on paraffin sections from embryos and adult C57Bl/6J wild-type (WT) mice using Grip2 and Notch3 antisense cRNA probes, as described previously. 7
Histological Analysis
Whole-mount staining for β-galactosidase activity was performed as described. 18 The middle cerebral artery was examined by highresolution optical microscopy on semithin sections and electron microscopy on ultrathin sections, as described previously. 18 Frozen brain sections were stained with rabbit anti-Grip2C polyclonal antibody 27 and mouse anti-α-smooth muscle actin monoclonal antibody (clone A4, Dako). Paraffin sections were stained with rabbit antismooth muscle myosin heavy chain polyclonal antibody (Biomedical Technologies Inc).
Vascular Reactivity Analysis
Segments of the posterior cerebral artery or caudal artery were isolated from Grip2 mutant male mice, SM-RBPJ-KO mice, and WT littermates and mounted in a video-monitored perfusion system (Living Systems Instrumentation), as previously described. 28 Vasoreactivity to acetylcholine, phenylephrine, and potassium chloride was examined on pressurized (50 mm Hg) vessels. Myogenic tone was measured by increasing intraluminal pressure by steps from 10 to 100 mm Hg.
Statistical Analysis
Data are expressed as mean±SEM. Two-group comparisons were analyzed by the 2-tailed t test for independent samples. Multiple comparisons were evaluated by 1-factor ANOVA followed by the Bonferroni post hoc test. P values <0.05 were considered significant.
Results

Notch3-Dependent Transcriptome in Distal Arteries
In an attempt to identify genes that serve as downstream effectors of Notch3 in the context of maturing distal artery, we compared the gene expression profile of arteries from Notch3 −/− (Notch3KO) and WT mice by an RNA microarray analysis. The caudal artery was collected from 1-monthold mice, the final stage of artery maturation. Of the ≈30 000 known genes arrayed on the chip, ≈36% were present in the WT arteries. A total of 188 distinct probe sets, corresponding to 159 transcripts, were identified as differentially regulated in the mutant (>1.5-fold change; P<0.05) compared with control arteries. Among these, 103 transcripts were found upregulated and 56 were downregulated ( Table I in Because the Notch receptors function as transcriptional activators, we prioritized the group of downregulated genes. When we applied a further selection step to this group of genes, a stringent pairwise comparison, the number of genes of interest was narrowed down to 17. Next, we validated the microarray results by QRT-PCR analysis of independently obtained caudal artery RNA samples (n=4 per genotype) and of a set of brain artery RNA samples (n=3 per genotype) collected from 1-month-old Notch3KO and WT mice. The QRT-PCR results showed that all of these were downregulated in Notch3KO caudal or brain arteries, confirming the validity of our microarray approach (Table) . Of these genes, 16 were significantly downregulated in the Notch3KO caudal arteries, most of them at fold ratios comparable with those in the global gene profile, and 15 were downregulated in the Notch3KO brain arteries.
Of these 17 Notch3-regulated genes, 3 genes (Pln [phospholamban], S1pr3 [sphingosine-1-phosphate receptor 3], and Kv1.5 [potassium voltage-gated channel, shaker-related subfamily, member 5]) have an established role in the regulation of arterial tone or SMC function. [29] [30] [31] Two other genes (Cdh6 [cadherin-6] and Ptp4a3 [protein-tyrosine phosphatase 4a3]) have documented expression in the vasculature. 32, 33 The subset of 15 genes, identified as downregulated in the Notch3KO brain arteries, was chosen for further characterization.
Postnatal Deletion of RBP-Jκ in SMC Recapitulates Structural Defects, Functional Alterations, and Molecular Changes of Brain Arteries Induced by Loss of Notch3
We first investigated the requirement of smooth muscle RBP-Jκ for the expression of Notch3 target genes. We generated mice with SMC deletion of RBP-Jκ (SM-RBP-J-KO) by mating a conditional allele of RBP-Jκ (RBP-J flox ) 21 with a tamoxifen-inducible CreER driver mouse line (SMMHC-CreER T2 ), which expresses an inducible Cre recombinase under the control of smooth muscle myosin heavy chain promoter. 22 Our previous work suggested that, in distal arteries, Notch3 operates in the postnatal period. 7 Consequently, we induced deletion of RBP-Jκ immediately after birth ( Figure I in the online-only Data Supplement).
Morphological inspection of the brain from 1-month-old mice revealed strong enlargement of the arteries in SM-RBP-J-KO mice (n=5) compared with control mice (n=6). Highresolution optic microscopy analysis showed marked thinning of SMC and dilation of mutant arteries with a less festooned elastica lamina ( Figure 1A -1D and 1G). Remarkably, immunostaining for smooth muscle myosin heavy chain, a common marker of contractile SMC, was roughly preserved in mutant brain arteries ( Figure 1E and 1F). Overall, arterial defects of SM-RBP-J-KO resembled those of Notch3KO mice at the histological level ( Figure II in the online-only Data Supplement). Furthermore, SM-RBP-J-KO mice (n=6) exhibited strongly reduced myogenic tone within the cerebral arteries compared with control mice (n=5, RBP-Jκ flox/flox treated with tamoxifen; Figure 1H ). Of note, acetylcholine-induced dilation and phenylephrine-induced or potassium chloride-induced contractile responses were also attenuated in mutant arteries ( Figure III SMMHC-CreER T2 treated with vehicle; Figure 1H ). Thus, these data establish the postnatal requirement of smooth muscle RBP-Jκ for proper maturation of distal arteries and indicate that, in this context, Notch3-signaling conforms to the canonical RBP-Jκ pathway.
Categorization of Notch3-RBP-Jκ Downregulated Genes
The list of genes identified as downregulated in brain arteries of Notch3KO and SM-RBP-J-KO mice likely includes a combination of immediate and late targets, as well as genes whose changes correspond to physiological adaptation. To discriminate between these distinct classes of genes and pinpoint the immediate targets, we assessed mRNA expression levels in the brain arteries upon transient blockade of the Notch pathway. Mice were treated with GSI, which inhibit the cleavage that releases the Notch intracellular domain from the plasma membrane required for Notch signaling, for 3 to 5 consecutive days. To control for efficient Notch pathway blockade, we used the notch activity sensor line, which expresses the β-galactosidase gene under the control of a minimal promoter containing multiple RBP-Jκ response elements, and monitored the expression level of β-galactosidase mRNA upon GSI treatment. 18 Diminished expression of β-galactosidase mRNA was detected in the brain arteries of GSI-treated mice as early as the third day, and decreased expression reached statistical significance at day 5. Of interest, Notch3, the expression of which is dependent on Notch signaling, 34 was also significantly downregulated from the third day of GSI treatment (Figure 2A ).
Of the 15 Notch3-regulated genes tested, 6 genes were found to be downregulated upon GSI treatment, whereas the others showed either no change or opposite trends ( Figure  2B and Table II in the online-only Data Supplement). Nrip2 and Pgam2 were significantly downregulated from day 3, and decreased expression of these 2 genes was further accentuated at day 5. Grip2 and Kv1.5 also had decreased transcript level from day 3, but downregulation of these 2 genes reached statistical significance at day 5. The latter genes, Susd5 and Xirp1, showed significant downregulation only after 5 days of GSI treatment. Thus, the quick response to in vivo Notch inactivation of these genes is consistent with the possibility that these 6 genes be immediate targets.
Grip2 Is Expressed in SMC of Distal Arteries
Further analysis focused on the characterization of Grip2, which displayed pronounced downregulation upon genetic and pharmacological inactivation of the Notch pathway. Grip2 encodes a 130-kDa multi-post synaptic density protein (PSD95)/disc large tumor suppressor (Dlg1)/zonula occludens-1 protein (ZO-1) (PDZ) domain-containing protein, highly enriched in the brain. It belongs to a small family of cytoplasmic scaffolding proteins (Grip1 and Grip2) known to interact with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-type glutamate receptor and to regulate its trafficking. 35, 36 The vascular expression and function of Grip2 have not yet been reported. Significantly, subunits of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors that interact with Grip2 protein have negligible expression in the brain arteries ( Figure IV in the online-only Data Supplement). Therefore, we first analyzed the expression pattern of Grip2 in detail. In situ hybridization showed Grip2 to be robustly expressed in the murine brain vessels, in addition to neurons, from postnatal day 1 and in adults ( Figure 3A and 3D) . Grip2 mRNA was also detected in the vessels of other organs, including the kidney, heart, skeletal muscle, and mesentery ( Figure 3B, 3C , 3E, and 3H; data not shown). Interestingly, Grip2, like Notch3, displayed preferential expression in arteries ( Figure 3C and 3F ). SMC expression of Grip2, suspected by in situ hybridization analysis, was confirmed by immunohistochemistry using a α-Grip-2-specific antibody in combination with the α-smooth muscle actin SMC marker ( Figure 3G-3I ). Finally, Grip2 protein was detected in WT brain arteries by immunoblot analysis and found to be strongly downregulated in Notch3KO arteries ( Figure 3J ).
Grip2 Encodes an Arterial Isoform Regulated by the Notch3-RBP-J Pathway
Previously, 3 distinct GRIP-2 isoforms have been described in rat, including a palmitoylated (pAMPA receptor binding protein [ABP]-L) and a nonpalmitoylated (ABP-L) long variant containing 7 PDZ domains and a shorter variant (ABP-S) lacking the seventh PDZ domain. These 3 variants are generated by alternate leader exon usage (arbitrarily named exon 1b, 1c, and 1d) and alternate splicing of exon 21. 37 In silico analysis showed that the rat and mouse Grip2 loci shared the same structure with conserved exons 1b, 1c, and 1d located 19 000 to 77 000 bp upstream of exons 2 to 24, whereas human Grip2 locus exhibited a slightly different structure lacking exon 1c ( Figure 4A ). Importantly, careful inspection of the databases revealed the existence of an additional GRIP-2 variant in humans (NM_001080423) highly homologous to pABP-L and ABP-L isoforms, but which differs in its N terminus by the usage of 2 novel 5ʹ exons, arbitrarily denoted 1a and 1aʹ. Alignment of the rat and mouse genomic sequences against the human sequence revealed conserved sequences (73%-77%) to exon 1a, which had 1 conserved inframe ATG codon, whereas sequence of exon 1aʹ was much more divergent (53%-61%) and lacked an inframe ATG in the rat ( Figure 4A ).
RT-PCR experiments, using sense primers specific of each leader exon against a common antisense primer in the 3ʹUTR, followed by DNA sequencing of the amplification products established the existence of 4 distinct transcripts arising from exons 1a, 1b, 1c, and 1d in the murine brain or isolated brain arteries. Despite repeated efforts, we were unable to amplify a transcript containing exon 1aʹ. Remarkably, these 4 transcripts exhibited distinct expression profiles in total brain versus the tail and brain arteries. Exon 1b-inclusive transcript (encoding for ABP-L) was abundantly expressed in both the brain and isolated arteries, whereas expression of exon 1d-and 1a-inclusive transcripts encoding pABP-L and ABP-L vascular was essentially restricted to brain and isolated arteries, respectively. Exon 1c-inclusive transcript (encoding ABP-S) was barely detectable in total brain and vascular tissues ( Figure 4B and 4C). B and C, Reverse transcription polymerase chain reaction (RT-PCR) analysis of Grip2 isoforms in total brain, brain arteries, and caudal arteries. cDNAs were prepared from 1 µg of total RNA of each tissue, amplified with a pair of primers specific for each isoform and separated in agarose gels (B). Expression level of Grip2 isoforms was normalized against total Grip2 (C). D and E, RT-PCR analysis of Grip2 isoforms in brain arteries from Notch3KO and control mice. Expression level of Grip2 isoforms and total Grip2 was normalized against β-actin. F and G, RT-PCR analysis of Grip2 isoforms in brain arteries from SM-RBP-J-KO and control mice. Expression level of Grip2 isoforms and total Grip2 was normalized against β-actin. *P<0.05; **P<0.01; and ***P<0.001.
Next, we assessed the expression of Grip2 isoforms in the brain arteries of Notch3-null and SM-RBP-J-KO mice. Expression of the ABP-L vascular transcript was strongly downregulated in Notch3KO mice, and this downregulation was even more pronounced in SM-RBP-J-KO mice. Levels of the ubiquitous ABP-L variant did not significantly change in Notch3KO and SM-RBP-J-KO mice. Of note, expression of the brain-specific pABP-L was either unchanged or increased in the absence of Notch3 (Figure 4D-4G) . Together, the results indicate that Grip2 encodes a vascular isoform and that the Notch3-RBP-Jκ pathway preferentially regulates this isoform.
A Grip2 Mutation in the Mouse Attenuates Myogenic Tone in the Cerebral Arteries
Next, we considered whether Grip2 expression in SMC might contribute to arterial SMC maturation or differentiation in maturing brain arteries and myogenic responses within the cerebrovasculature. We analyzed Grip2 neo/neo mice, which have a constitutive disruption of the Grip2 gene by the insertion of a phosphoglycerate kinase-neo cassette into exon 3, which encodes the PDZ domain 1. These mice were previously reported to exhibit no overt phenotype. 24 Analysis of brain artery morphology and SMC structure using high-resolution optical microscopy and electron microscopy revealed no overt defect in homozygous Grip2 mutant mice (n=6) compared with WT littermates (n=5; Figure 5A ). One of the important functions of SMC is to maintain arterial blood pressure by regulating the diameter of resistance arteries. We measured systolic and diastolic blood pressure in conscious Grip2 mutant and control mice using the tail cuff technique. We found that Grip2 mutant mice exhibited a moderate but significant reduction in both systolic and diastolic blood pressures, although the heart rate was not altered ( Figure V in the online-only Data Supplement). Next, we examined the vasoreactivity and myogenic responses of isolated posterior cerebral arteries from mutant (n=8) and control (n=7) mice. The relaxation to acetylcholine and the contractile responses to phenylephrine or potassium chloride were comparable in mutant and control mice ( Figure VI in the online-only Data Supplement). In contrast, pressure-induced contraction was markedly attenuated in mutant arteries compared with control arteries (Figure 5B ). For example, at 50 mm Hg, myogenic tone was reduced by 35% in the mutant arteries. Because reduced myogenic tone in Grip2 mutant mice might be caused by an augmented endothelial dilator influence rather than a true reduction in SMC responsiveness, myogenic tone was further measured after pharmacological blockade of the endothelial dilator influence. NO production was inhibited with N(G)-nitro-L-arginine methyl ester, and endothelium-derived hyperpolarizing factor-mediated relaxation was inhibited with specific antagonists of small and intermediate calciumactivated potassium channels (SK Ca and IK Ca ). 38 Importantly, myogenic tone remained significantly reduced in Grip2 mutant mice, despite the presence of these inhibitors ( Figure VII in the online-only Data Supplement). Thus, our findings reveal a role for Grip2 in the control of myogenic responses in the brain arteries. Interestingly, myogenic tone of caudal artery, which expresses 10-fold less Grip2 mRNA, was unaffected by Grip2 mutation ( Figure VIII in the online-only Data Supplement).
Because of the mild phenotype of Grip2 mutant mice, we looked whether Grip1 might compensate for Grip2 mutation. QRT-PCR showed that the Grip1 transcript level was unaltered in Grip2 mutant arteries (data not shown). We then tested the hypothesis that introduction of the neo cassette into the Grip2 gene, which exhibits a complex genomic structure, may not lead to a null allele. QRT-PCR analysis on total RNA prepared from brain or arteries, using a set of primers amplifying all 4 isoforms, showed comparable level of Grip2 transcript in the mutant and control samples, indicating that introduction of the neo cassette did not result in mRNA decay ( Figure IXA in the online-only Data Supplement). Immunoblot analysis of brain and brain artery lysates, with an antibody raised against the region comprised between the sixth and seventh PDZ domain of Grip2, revealed that homozygous Grip2 mutant mice lacked the 130-kDa Grip2 protein seen in WT animals but expressed a shorter ≈90-kDa protein, and that Grip2 heterozygous mice expressed both 130-kDa and ≈90-kDa proteins ( Figure IXB and IXC in the online-only Data Supplement). Thus, these results strongly suggest that the Grip2 mutation produces N-terminally truncated Grip2 protein that may behave as a hypomorphic allele and account for the mild phenotype observed in these mice.
Discussion
It has recently become clear that Notch3 is a major SMC receptor involved in the physiology and pathology of distal arteries, particularly of brain arteries. Here, we used constitutive and inducible loss-of-function genetics, in combination with inhibitors in vivo, to investigate the molecular mechanisms acting downstream of Notch3 in the distal arteries. This effort led to the identification of a core set of novel Notch3-regulated genes in the caudal and cerebral arteries. We establish the Figure 5 . Brain arteries of glutamate receptor-interacting protein 2 (Grip2) mutant mice exhibit normal structure, but reduced myogenic responses. A, Representative semithin sections of middle cerebral artery from Grip2 wild-type (left) and mutant (right) mice stained with toluidine blue showing no overt structural defect in the mutant artery. Scale bar, 10 µm. B, Response of cerebral artery to stepwise increase in pressure in wild-type (n=7) and Grip2 mutant mice (n=8) shows that myogenic tone is significantly attenuated in mutant mice. *P<0.01. requirement of smooth muscle RBP-Jκ for the expression of Notch3 target genes, indicating that, in the context of maturing distal arteries, Notch3 signaling conforms to the canonical RBP-Jκ pathway. SMC inactivation of RBP-Jκ in mouse neonates leads to major structural and functional defects within the cerebral arteries of young adult mice that closely resemble those seen in mice constitutively lacking Notch3. Importantly, expression of most of the newly discovered Notch3 targets is significantly diminished in the brain arteries of mice lacking RBP-Jκ in SMC. Of interest, we find that RBP-Jκ is required after birth, corroborating our previous observation that maturation of distal arteries predominantly occurs after birth.
Our study uncovers a large number of genes that have not been linked to SMC function before. To provide an example of the functional significance of these genes, we analyzed the in vivo role of Grip2, which exhibits profound downregulation upon genetic and pharmacological inactivation of Notch. Grip2 encodes a multi-PDZ-containing protein, with an established role in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-receptor trafficking in the neurons. We present several lines of evidence that Grip2 functions downstream of Notch3/ RBP-Jκ to regulate myogenic tone in the brain arteries. First, we show that Grip2 transcript and proteins are detected, in addition to neurons, in SMC of distal arteries, including the brain arteries. Second, we find that Grip2 encodes, in addition to a neuronal isoform, a vascular isoform. Of interest, Notch3/RBP-Jκ specifically regulates the vascular isoform. Third, we provide evidence that Grip2 mutant mice, although still expressing a truncated Grip2 protein, share phenotypic similarities with mice completely lacking Notch3. Specifically, we show that Grip2 mutant mice have strongly attenuated myogenic responses in the cerebral arteries. Similar to Notch3-null mice, this defect is anticipated to compromise cerebral blood flow autoregulation particularly in response to elevation of systemic arterial blood pressure. 7 Interestingly, comparative analyses on cerebral arteries versus caudal arteries revealed that these 2 distal arteries have differential dependency on Grip2, which is likely related to differential Grip2 expression level. Indeed, we found that the caudal artery, which expresses 10-fold less Grip2 than cerebral arteries, has preserved myogenic tone in Grip2 mutant mice. Hence, this finding suggests that Notch3, as the other Notch receptors, likely functions using a highly context-dependent set of downstream effectors. We did not find evidence of altered maturation or arterial differentiation of SMC in Grip2 mutant mice, as seen in Notch3-null mice. However, it is tempting to speculate that mice completely lacking Grip2 in SMC might exhibit a more severe vascular phenotype.
How Grip2 mediates Notch3-dependent myogenic responses in cerebral arteries is yet to be determined. PDZ domains mediate protein-protein interactions by binding to the C termini of its target proteins. In addition to alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, Grip proteins bind various receptors, transmembrane ligands, and signaling and cytoskeletal proteins and may act as a scaffold for the assembly of multiprotein signaling complex. [39] [40] [41] [42] Among these, neuron-glial antigen2 proteoglycan and ephrin-B2 ligand are expressed in SMC, and ephrin-B2 ligand is required for SMC to spread and associate with small-diameter blood vessels. 43 Additional studies are required to determine the functional significance of these interactions in the context of cerebral arteries.
Also, the functional significance of 4 other genes that we identified as immediate and persistent responders to in vivo Notch pathway blockade in the brain arteries remains to be clarified. Xirp1 encodes an F-actin-binding protein of unclear function, 44 and Susd5 is structurally related to a protein superfamily containing hyaluronic acid-binding domains. 45 Nrip2 has been reported to bind and modulate the activity of nuclear receptors, including retinoic acid receptor and thyroid hormone receptor, 46 and Pgam2 encodes the muscle isoform of phosphoglycerate mutase, an enzyme of the glycolytic pathway that converts glucose into pyruvate. 47 Our study also uncovers one interesting small group of genes with an established role in SMC function and vessel tone. This group includes Kv1.5 that quickly responds to in vivo Notch pathway blockade in the brain arteries. Kv1.5 encodes a pore-forming subunit that coassembles with other Kv1α subunits to form heterotetrameric or homotetrameric voltagegated potassium channels (Kv1). Overexpression in the cerebral arteries of a dominant-negative form of Kv1.5 enhances myogenic constriction, whereas overexpression of a WT version decreases it. 48 Functionally, Kv1 channels counteract the depolarizing effects of intraluminal pressure and vasoconstrictors by exerting a hyperpolarizing influence. 31 The other genes include S1pr3 that encodes a G-protein-coupled receptor. Two recent studies, involving genetic or pharmacological inactivation of S1pr3, provide evidence that this receptor is the major contributor to sphingosine-1-phosphate-induced vasoconstriction in the cerebral circulation. 30, 49 Finally, phospholamban is a small homopentameric phosphoprotein in the sarcoplasmic reticulum, which regulates sarcoplasmic reticulum Ca 2+ load. Nelson and colleagues 50 have established the crucial role of phospholamban in regulating Ca 2+ uptake into the sarcoplasmic reticulum, Ca 2+ spark frequency, and thus large-conductance Ca 2+ -activated K + channel activity in SMC of cerebral arteries. Functionally, activation of Ca 2+ -activated K + channels, which opposes depolarization of SMC, is one critical negative feedback mechanism responsible for controlling the extent of myogenic constriction, particularly in the brain arteries. 51 We acknowledge several caveats of in vivo studies such as ours. We chose to profile gene expression in whole arteries rather than cultured SMC, which are extremely prone to phenotypic changes. We used the caudal artery, which is the longest distal artery providing sufficient quantity of RNA to synthesize cRNA probes without an amplification step and in which SMC make up the majority of the vessel. Furthermore, our previous work showed that the caudal artery displays the characteristic structural and functional alterations induced by the absence of Notch3. 7, 10 Although the results show that this strategy yielded biologically relevant Notch3-target genes, we did not fish some recently discovered vascular targets of Notch, such as PDGFR-β, integrin β3, or Jagged1. 19, 20, 52 This discrepancy could be the result of ≥1 of the following causes. First, this may reflect the diversity of Notch effectors among different vascular beds. As an example, Jagged1 has been validated in the maturing aorta 52 and integrin β3 in the maturing retinal vessels. 20 Second, this may represent the differences between studies done in cultured cells exposed to transient Notch activation versus the present study done in tissues with persistent Notch inactivation. The latter in vivo approach is presumably less appropriate for the discovery of genes exhibiting discrete or transient changes upon manipulation of Notch activity. Furthermore, the gene expression profile changes in the Notch3KO mouse model likely integrate compensatory mechanisms. As an example, we found that HeyL expression was downregulated in the brain arteries of SM-RBP-J-KO mice and upon GSI treatment, whereas it was unchanged in Notch3KO arteries (data not shown). However, comparison of in vitro, ex vivo, and in vivo vascular SMC gene expression profiles indicates that several Notch3 targets identified in this study, including, for example, Nrip2, Kv1.5, and Grip2, have their expression almost lost in cultured SMC as early as the first passage (data not shown).
In conclusion, we have carried out in vivo genome-wide microarray studies using distal arteries from a loss-of-function Notch3 mouse model. We validated by QRT-PCR in the tail and brain arteries a core set of 17 Notch3-target genes, including 6 genes that are immediate and persistent responders to in vivo Notch blockade in the cerebrovasculature, and established the postnatal requirement of RBP-Jκ in SMC for their expression.
The data indicate that Notch3 transcriptome provides potential for modulating myogenic response in the brain arteries. For example, we identified Kv1.5, which counteracts the depolarizing effects of intraluminal pressure, and Grip2, a novel regulator of myogenic tone. A better understanding of Notch3 signaling promises to provide insight into the basic mechanisms of vSMC biology and myogenic tone regulation in the cerebral arteries. Furthermore, by identifying Notch3-regulated transcriptome, this study provides an important resource of candidate genes for hereditary small vessel disease of the brain.
